The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases

[1]  P. Iyengar,et al.  Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial , 2018, JAMA oncology.

[2]  R. Klement.  Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  R. Semrau,et al.  Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  J. Lee,et al.  Local Consolidative Therapy versus Maintenance Therapy/Observation for Patients with Oligometastatic Non-Small Cell Lung Cancer without Progression after Front-Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study , 2016, The Lancet. Oncology.

[5]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Oliver Blanck,et al.  Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Michael Velec,et al.  Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases. , 2015, International journal of radiation oncology, biology, physics.

[8]  Y. Niibe,et al.  Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation. , 2015, Anticancer research.

[9]  J. Ledermann,et al.  O-018Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC) , 2015 .

[10]  N. Andratschke,et al.  Stereotactic radiation therapy for liver metastases: factors affecting local control and survival , 2015, Radiation Oncology.

[11]  M. Høyer,et al.  Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  M. Scorsetti,et al.  Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer , 2015, Journal of Cancer Research and Clinical Oncology.

[13]  Merina Ahmed,et al.  Stereotactic body radiotherapy for oligometastases. , 2013, The Lancet. Oncology.

[14]  Michael Lock,et al.  Radiotherapy for liver metastases: a review of evidence. , 2012, International journal of radiation oncology, biology, physics.

[15]  Thomas Lacornerie,et al.  Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? , 2011, International journal of radiation oncology, biology, physics.

[16]  A. Koong,et al.  Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. , 2010, International journal of radiation oncology, biology, physics.

[17]  V. Heinemann,et al.  Radiosurgery of Liver Tumors: Value of Robotic Radiosurgical Device to Treat Liver Tumors , 2010, Annals of Surgical Oncology.

[18]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[19]  Y. Niibe,et al.  Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy , 2010, Japanese journal of clinical oncology.

[20]  Anand Mahadevan,et al.  Stereotactic body radiation therapy for liver metastases. , 2009, European journal of cancer.

[21]  G. Lockwood,et al.  Phase I study of individualized stereotactic body radiotherapy of liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  W. Franklin,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  C. Cleeland,et al.  Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. , 2007, Journal of neurosurgery. Spine.

[25]  M. Schell,et al.  Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. , 2007, International journal of radiation oncology, biology, physics.

[26]  U. Haedinger,et al.  Stereotactic radiotherapy of primary liver cancer and hepatic metastases , 2006, Acta oncologica.

[27]  Robert D Timmerman,et al.  A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. , 2005, International journal of radiation oncology, biology, physics.

[28]  F. Lohr,et al.  Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.